Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Pathol Res Pract ; 204(5): 329-34, 2008.
Article in English | MEDLINE | ID: mdl-18291599

ABSTRACT

We infected HeLa cells with low (10(-9) units), medium (10(-6) units), and high (10(-2) units) influenza B titers and compared the resulting human papilloma virus (HPV), retinoic acid receptor alpha subunit (RARalpha) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA content of surviving infected hosts with that of their uninfected precursors by semi-quantitative reverse transcriptase/polymerase chain reaction amplification (RT/PCR). This comparison revealed a moderate and drastic dependence of HPV and RARalpha mRNA content, respectively, but a complete independence of GAPDH mRNA expression on viral titer. A mechanism of adoptive replacement of tolerable cellular with viral gene expression was proposed to explain these findings. We conclude that the reported ability of influenza B viruses to specifically target and eliminate the cervical adenocarcinoma HeLa cell line studied may find practical applications in biological cancer management.


Subject(s)
Adenocarcinoma/virology , Influenza B virus/pathogenicity , Oncolytic Virotherapy , Oncolytic Viruses/pathogenicity , Uterine Cervical Neoplasms/virology , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/therapy , Antigens, Viral/metabolism , Apoptosis , Cell Survival , Female , Gene Expression Regulation, Neoplastic , Gene Expression Regulation, Viral , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , HeLa Cells , Human papillomavirus 18/genetics , Human papillomavirus 18/metabolism , Humans , Influenza B virus/genetics , Influenza B virus/immunology , Oncolytic Viruses/genetics , Oncolytic Viruses/immunology , Phenotype , RNA, Messenger/metabolism , Receptors, Retinoic Acid/genetics , Receptors, Retinoic Acid/metabolism , Retinoic Acid Receptor alpha , Reverse Transcriptase Polymerase Chain Reaction , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/metabolism , Uterine Cervical Neoplasms/therapy
2.
Onkologie ; 29(8-9): 372-5, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16974114

ABSTRACT

BACKGROUND: Imprint cytology may provide a fast and accurate method for intraoperative screening of sentinel lymph nodes, so a decision can be made regarding whether to perform axillary clearance during primary surgery. If the findings are negative, in many cases axillary dissection can be omitted. PATIENTS AND METHODS: 128 sentinel nodes from a cohort of 87 patients that had been identified using technetium-99m nanocolloid as a radioactive tracer and Patent blue dye were dissected for rapid Diff-Quick stained touch preparations. Intraoperative evaluation of sentinel node status by imprint cytology was correlated with histopathological results of permanent sections. Tumor-negative nodes in routine paraffin sections were further investigated with the employment of an anti-cytokeratin antibody. RESULTS: 36 of all sentinel nodes harbored metastases in the paraffin sections, of which 32 were identified by imprint cytology (sensitivity 88.8%). 3 sentinel nodes were positive by imprint cytology and negative by histopathology of the paraffin sections. Comparison of the results of the touch preparations with the final histopathology (hematoxylin-eosin and anticytokeratin antibody stains) demonstrated a sensitivity of 83.3% and a negative predictive value of 92.5%. The specificity and positive predictive value were 100% each. CONCLUSIONS: Touch imprint cytology is potentially useful for intraoperative evaluation of sentinel lymph nodes in breast cancer patients.


Subject(s)
Breast Neoplasms/pathology , Lymph Nodes/pathology , Sentinel Lymph Node Biopsy/methods , Adult , Aged , Breast Neoplasms/surgery , Female , Humans , Intraoperative Care/methods , Lymph Node Excision , Lymph Nodes/surgery , Lymphatic Metastasis , Middle Aged , Prognosis , Reproducibility of Results , Sensitivity and Specificity
3.
Article in English | MEDLINE | ID: mdl-17982609

ABSTRACT

Implantation of cancer cells from needle biopsy has been reported in a wide range of malignancies. Fine needle aspiration biopsy has become an accepted method for assessment of thyroid nodules. Local reappearance of thyroid cancer from needle track dissemination is a rare complication of thyroid aspiration. A 45-year-old female developed local recurrence of papillary thyroid carcinoma four years after aspiration biopsy and thyroidectomy. Metastatic deposits appeared in the skin and the sternocleidomastoid muscle. The linear array and the site of metastases implied that seeding most probably resulted from the needle biopsy.


Subject(s)
Biopsy, Fine-Needle/adverse effects , Carcinoma, Papillary/secondary , Muscle Neoplasms/secondary , Neoplasm Seeding , Skin Neoplasms/secondary , Thyroid Neoplasms/pathology , Female , Humans , Middle Aged , Muscle Neoplasms/etiology , Skin Neoplasms/etiology
4.
Onkologie ; 28(8-9): 423-6, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16160405

ABSTRACT

BACKGROUND: Coexistence of B- and T-cell lymphoid malignancies has been reported sporadically. CASE REPORT: A 68-year-old woman developed a lymphoid neoplasm in the large intestine and a second lymphoid neoplasm in the esophagus, 24 months after the diagnosis of the first lymphoma. Immunophenotypic analyses were consistent with extranodal marginal zone B-cell mucosa-associated lymphoid tissue type (MALT type) and peripheral T-cell unspecified lymphomas in the large intestine and the esophagus, respectively. The molecular analysis confirmed the B-clonal genotype of the first lymphoma, and disclosed a biclonal genotype of the second one (composite T- and B-cell lymphoma). No evidence of Epstein-Barr virus (EBV) association was shown in either tumor. CONCLUSION: B- and T-cell neoplasms represent two distinct malignancies rather than progression of the same neoplastic clone.


Subject(s)
Colonic Neoplasms/pathology , Esophageal Neoplasms/pathology , Immunophenotyping , Lymphoma, B-Cell, Marginal Zone/pathology , Lymphoma, T-Cell, Peripheral/pathology , Neoplasms, Second Primary/pathology , Aged , Antibodies, Viral/blood , B-Lymphocytes/immunology , B-Lymphocytes/pathology , Biomarkers, Tumor/genetics , Biopsy , Colonic Neoplasms/genetics , Colonic Neoplasms/immunology , Colonic Neoplasms/surgery , Epstein-Barr Virus Infections/genetics , Epstein-Barr Virus Infections/immunology , Epstein-Barr Virus Infections/pathology , Esophageal Neoplasms/genetics , Esophageal Neoplasms/immunology , Esophagus/pathology , Female , Gene Rearrangement/genetics , Genes, T-Cell Receptor gamma , Herpesvirus 4, Human/immunology , Humans , Immunoglobulin M/blood , Intestinal Mucosa/pathology , Lymphoma, B-Cell, Marginal Zone/genetics , Lymphoma, B-Cell, Marginal Zone/immunology , Lymphoma, B-Cell, Marginal Zone/surgery , Lymphoma, T-Cell, Peripheral/genetics , Lymphoma, T-Cell, Peripheral/immunology , Mitotic Index , Neoplasm Invasiveness , Neoplasms, Second Primary/genetics , Neoplasms, Second Primary/immunology , Neoplasms, Second Primary/surgery , Polymerase Chain Reaction , T-Lymphocytes/immunology , T-Lymphocytes/pathology
5.
Onkologie ; 28(6-7): 356-8, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15933425

ABSTRACT

BACKGROUND: Anaplastic lymphoma kinase (ALK) expression has not been described in neutrophil-rich anaplastic large cell lymphoma (NR-ALCL). CASE REPORT: A 12-year old female with a 4-weeks history of a non-resolving bump over the forehead resulting from injury, was diagnosed of stage IE cutaneous T-cell lymphoma, and radiation was employed. Shortly after completion of therapy, there was progress of the disease on the soft tissue of the right hand, and bone marrow involvement was also found. A fine-needle aspiration of the hand mass was performed, and a diagnosis of CD30+/ALK+ NR-ALCL, was rendered. METHODS: We studied the morphological characteristics of CD30+/ALK+ NR-ALCL using histological methods. A panel of antibodies were used to establish diagnosis and subtyping. In addition EBV status and molecular cytogenetics were determined. CONCLUSIONS: ALK-ALCL arising in the skin represents a single disease with a broad spectrum of morphology; clinicians and pathologists should be aware of this neutrophil-rich (NR) variant with aggressive clinical presentation.


Subject(s)
Lymphoma, Large B-Cell, Diffuse/blood , Lymphoma, Large B-Cell, Diffuse/pathology , Neutrophils/pathology , Protein-Tyrosine Kinases/blood , Skin Neoplasms/blood , Skin Neoplasms/pathology , Anaplastic Lymphoma Kinase , Carcinoma/blood , Carcinoma/pathology , Child , Female , Head Injuries, Closed/pathology , Humans , Incidental Findings , Leukocyte Count , Receptor Protein-Tyrosine Kinases
6.
Theor Biol Med Model ; 2: 1, 2005 Jan 11.
Article in English | MEDLINE | ID: mdl-15644135

ABSTRACT

BACKGROUND: Ki-1 (CD30) antigen expression is not found on peripheral blood cells but its expression can be induced in vitro on T and B lymphocytes by viruses and lectins. Expression of CD30 in normal tissues is very limited, being restricted mainly to a subpopulation of large lymphoid cells; in particular, cells of the recently described anaplastic large cell lymphoma (ALCL), the Reed-Sternberg (RS) cells of Hodgkin's lymphoma and scattered large parafollicular cells in normal lymphoid tissues. More recent reports have described CD30 expression in non-hematopoietic and malignant cells such as cultured human macrophages, human decidual cells, histiocytic neoplastic cells, mesothelioma cells, embryonal carcinoma and seminoma cells. RESULTS: We investigated the immunohistochemical expression of CD30 antigen in 15 paraffin-embedded tissue samples representing small intestines from fetuses after spontaneous abortion in the 8th, 10th and 12th weeks using the monoclonal antibody Ki-1. Hormones had been administered to all our pregnant women to support gestation. In addition, a panel of monoclonal antibodies was used to identify leukocytes (CD45/LCA), B-lymphocytes (CD20/L-26) and T-lymphocytes (CD3). Our findings were correlated with those obtained simultaneously from intestinal tissue samples obtained from 15 fetuses after therapeutic or voluntary abortions. CONCLUSIONS: The results showed that: (1) epithelial cells in the developing intestinal crypts express the CD30 (Ki-1) antigen; (2) CD30 expression in these epithelial cells is higher in cases of hormonal administration than in normal gestation. In the former cases (hormonal support of gestation) a mild mononuclear intraepithelial infiltrate composed of CD3 (T-marker)-positive cells accompanies the CD30-positive cells.


Subject(s)
Abortion, Spontaneous/metabolism , Embryo, Mammalian/cytology , Epithelial Cells/metabolism , Intestine, Small/cytology , Intestine, Small/embryology , Ki-1 Antigen/metabolism , Pregnancy Trimester, First/metabolism , Embryo, Mammalian/metabolism , Epithelial Cells/cytology , Female , Fetus/cytology , Fetus/metabolism , Gestational Age , Humans , Intestine, Small/metabolism , Pregnancy
7.
Arch Intern Med ; 162(11): 1237-44, 2002 Jun 10.
Article in English | MEDLINE | ID: mdl-12038941

ABSTRACT

BACKGROUND: We have documented a high prevalence of Helicobacter pylori infection in patients with glaucoma. OBJECTIVE: To evaluate the effect of H pylori eradication on the 2 most commonly used glaucoma parameters: intraocular pressure and visual field. METHODS: A total of 41 patients with glaucoma and 30 age-matched anemic controls underwent upper gastrointestinal endoscopies and gastric mucosal biopsies to detect the presence of H. pylori infection by histologic analysis and rapid urease test (CLOtest; Delta West, Draper, Utah). Saliva samples were also tested by CLOtest. Serum anti-H pylori-specific IgG was analyzed by enzyme-linked immunosorbent assay. Helicobacter pylori-positive patients received a triple eradication regimen (omeprazole, clarithromycin, and amoxicillin treatment), and all patients were observed for 2 years while remaining under the same antiglaucoma therapy. RESULTS: Helicobacter pylori was detected in 88% of glaucoma cases and in 47% of controls (P<.001). Helicobacter pylori eradication was successful in 83% of treated patients. At the 2-year clinical end point, glaucoma parameters (mean intraocular pressure and mean visual field parameters) were improved in the subgroup of patients where H. pylori eradication was successful (P<.001 for intraocular pressure; P< or =.01 for visual field parameters), but not in the other patients. CONCLUSION: Helicobacter pylori eradication may positively influence glaucoma parameters, suggesting a possible causal link between H pylori and glaucoma.


Subject(s)
Glaucoma, Open-Angle/epidemiology , Glaucoma, Open-Angle/microbiology , Helicobacter Infections/epidemiology , Helicobacter pylori , Aged , Causality , Comorbidity , Female , Glaucoma, Open-Angle/therapy , Humans , Intraocular Pressure , Male , Middle Aged , Prevalence , Visual Fields
SELECTION OF CITATIONS
SEARCH DETAIL
...